In addition, CDH5 promoted breast cancer progression via the transforming growth factor β (TGF-β) signalling pathway (Labelle et al, 2008) the same pathway that promotes cell proliferation and EMT in tumours with an invasive cellular phenotype (Yilmaz and Christofori, 2009). The gene discussed is TGFB1; the disease is neoplasm.